Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. The company was incorporated in 2005 and is based in Hyderabad, India.
Laurus Labs Dividend Announcement
• Laurus Labs announced a quarterly dividend of ₹0.40 per ordinary share which will be made payable on 2024-11-23. Ex dividend date: 2024-11-06
• Laurus Labs annual dividend for 2024 was ₹0.80
• Laurus Labs annual dividend for 2023 was ₹2.00
• Laurus Labs's trailing twelve-month (TTM) dividend yield is 0.16%
• Laurus Labs's dividend growth over the last five years (2018-2023) was 5.92% year
Laurus Labs Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-06 | ₹0.40 | quarterly | 2024-11-23 |
2024-05-08 | ₹0.40 | quarterly | 2024-05-25 |
2023-11-02 | ₹0.40 | quarterly | 2023-11-19 |
2023-10-30 | ₹0.40 | quarterly | |
2023-05-10 | ₹1.20 | quarterly | 2023-05-27 |
2022-11-03 | ₹0.80 | quarterly | 2022-11-20 |
2022-05-10 | ₹1.20 | quarterly | 2022-05-28 |
2021-11-17 | ₹0.80 | quarterly | 2021-11-27 |
2021-05-11 | ₹0.80 | quarterly | 2021-05-29 |
2021-02-08 | ₹0.40 | quarterly | 2021-02-27 |
2020-11-10 | ₹0.80 | quarterly | 2020-11-28 |
2020-07-01 | ₹1.00 | quarterly | 2020-08-08 |
2020-03-23 | ₹1.50 | quarterly | 2020-03-27 |
2019-07-03 | ₹1.50 | quarterly | 2019-08-10 |
2018-06-28 | ₹1.50 | quarterly | 2018-08-04 |
2017-07-06 | ₹1.50 | quarterly | 2017-08-17 |
Laurus Labs Dividend per year
Laurus Labs Dividend growth
Laurus Labs Dividend Yield
Laurus Labs current trailing twelve-month (TTM) dividend yield is 0.16%. Interested in purchasing Laurus Labs stock? Use our calculator to estimate your expected dividend yield:
Laurus Labs Financial Ratios
Laurus Labs Dividend FAQ
Other factors to consider when evaluating Laurus Labs as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Laurus Labs stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Laurus Labs's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Laurus Labs publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Laurus Labs distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Laurus Labs are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Laurus Labs sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Laurus Labs distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Laurus Labs declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Laurus Labs's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Laurus Labs's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.